Vol. 11 No. 3 (2020)

View Vol. 11 No. 3 (2020)

Published: 2020-09-30

Editorial

The headache and adverse events due to the use of personal protective equipment to combat Covid-19

Erlene Roberta Ribeiro dos Santos (Author)

55-56
- PDF
- HTML

Review

The role of TRPM8 in the pathophysiology of migraine

Eduardo de Almeida Guimarães Nogueira, Yara Dadalti Fragoso (Author)

57-60
- PDF
- HTML
CGRP: from history to clinical application - A review

Afonso Henrique Aragao, Joel Sanabria Duarte, Daniel Benzecry Almeida, Ricardo Ramina (Author)

61-67
- PDF
- HTML

Case Report

Pseudotumor cerebri secondary to secondary hypoparathyroidism and association to Fahr´s Syndrome: a case report

Patrick Giordanni Gomes Sampaio, Hiago Diniz Maracajá, Francielle Lopes de Araújo Batista, Virgínia Gabriela Nóbrega Figueiredo, Nátalia Meg Adijuto de Melo (Author)

68-71
- PDF
- HTML

Original

A framework for decision making of migraine treatment with anti- CGRP monoclonal antibodies: a guide for real-world practice and public policies

Reinilza Nunes da Gama, Thaiza Agostini Córdoba de Lima, Iron Dangoni Filho, Mario Fernando Prieto Peres (Author)

72-76
- PDF
- HTML

Commented Article

Anti-CGRP monoclonal antibodies in chronic cluster headache

Aline Turbino Neves Martins da Costa (Author)

77
- PDF
- HTML
Lasmiditan for the acute treatment of migraine: Subgroup analyses by prior response to triptans

Fabíola Dach Éckeli (Author)

78
- PDF
- HTML